ВИТАМИН D И РЕВМАТОИДНЫЙ АРТРИТ: ЧТО МЫ ЗНАЕМ СЕГОДНЯ?

1. <div><p>Nagpal S., Na S., Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662-87.</p><p>Mathieu C., Adorini L. The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents.Trends Mol Med 2002; 8: 174-9.</p><p>Lemire J. Vitamin D3, autoimmunity and immunosuppression. In: Vitamin D. 2nd ed. (D. Feldman, J.W. Pike, and F. Glorieux, eds). San Diego: Elsevier Academic Press, 2005: 1753-62.</p><p>J.M., Archer D.C., Beck L., Spiegelberg H.L. Immunosuppressive actions of 1,25-dihydroxyvitamin D3, preferential inhibition of Th1 functions. J Nutr 1995; 125: 1704-8.</p><p>Boonstra A., Barrat F.J., Crain C. et al. 1alpha,25-dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167: 4974-80.</p><p>Cutolo M. Vitamin D and autoimmune rheumatic diseases. Rheumatology 2009; 48: 210-2.</p><p>Hewison M., Adams J.S. Extra-renal 1α-hydroxylase activity and human disease. In: Vitamin D, 2nd ed. (D. Feldman, J. W. Pike, and F. Glorieux, eds). San Diego: Elsevier Academic Press, 2005; 1378-400.</p><p>Szodoray P., Nakken В., Gaal J. et al. The complex role of vitamin D in autoimmune diseases. Scand J Immun 2008; 68: 261-9.</p><p>Cantorna M.T., Hayes C.E., DeLuca H.F. 1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998; 128: 68-72.</p><p>Merlino L.A., Curtis J., Mikuls T.R. et al. Vitamin D is associated with lower risk of rheumatoid arthritis in older women: results from the Iowa Women's Health Study. Arthr Rheum 2004; 50: 72-7.</p><p>Costenbader K.H., Feskanich D., Holmes M. et al. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2008; 67: 530-5.</p><p>Nielen M.M., van Schaardenburg D., Lems W.F. et al. Vitamin D deficiency does not increase the risk of rheumatoid arthritis: comment on the article by Merlino et al. Arthr Rheum 2006; 54: 3719-20.</p><p>Feser M., Derber L.A., Deane K.D. et al. Plasma 25,OH vitamin D levels not associated with rheumatoid arthritis-related autoantibodies in individuals at elevated risk for rheumatoid arthritis. J Rheumatol 2009; 36(5): 943-6.</p><p>Iikuni N., Nakajima A., Inoue E. et al. What's in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity. Rheumatology 2007; 46: 846-8.</p><p>Cutolo M., Otsa K., Laas K. et al. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: northern versus southern Europe. Clin Exp Rheumatol 2006; 24: 702-4.</p><p>Patel S., Farragher T., Berry J. et al. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthr Rheum 2007; 56: 2143-9.</p><p>Craig S., Yu F., Curtis J.R. et al. Vitamin D Status and Its Associations with Disease Activity and Severity in African Americans with Recent-onset Rheumatoid Arthritis. J Rheumatol 2010; 37: (2): 275-81.</p><p>Haque U.J., Bartlett S.J. Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin Exp Rheumatol 2010; 28(5): 745-7.</p><p>Kerr G.S., Sabahi I., Richards J.S. et al. Prevalence of Vitamin D Insufficiency/Deficiency in Rheumatoid Arthritis and Associations with Disease Severity and Activity. J Rheumatol 2010; 38: 53-9</p><p>Garcia-Lozano J.R., Gonzalez-Escribano M.F., Valenzuela A. et al. Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur J Immunogenet 2001; 28: 89-93.</p><p>Goertz В., Fassbender W.J., Williams J.C. et al. Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients. Clin Exp Rheumatol 2003; 21: 333-9.</p><p>Gomez-Vaquero C., Fiter J., Enjuanes A. et al. Influence of the BsmI polymorphism of the vitamin D receptor gene on rheumatoid arthritis clinical activity. J Rheumatol 2007; 34: 1823-6.</p><p>Lee C.K., Hong J.S., Cho Y.S. et al. Lack of relationship between vitamin D receptor polymorphism and bone erosion in rheumatoid arthritis. J Korean Med Sci 2001; 16: 188-92</p><p>Mosekilde L. Vitamin D and the elderly. Clin Endocrinol 2005; 62: 265-81.</p><p>Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. Br Med J 2005; 330: 524-6.</p><p>Jackson C., Gaugris S., Sen S., Hosking D. The effect of cholecalciferol (vitamin D 3) on the risk of fall and fracture: a metanalysis. Q J Med 2007; 100: 185-92.</p><p>Kaz H., Johnson D., Kerry S. et al. Fall-related risk factors and osteoporosis in women with rheumatoid arthritis. Rheumatology 2004; 43: 1267-71.</p><p>Armstrong C., Swarbrick C.M., Pye S.R., O'Neill T.W. Occurrence and risk factors for falls in rheumatoid arthritis. Ann Rheum Dis 2005; 64: 1602-4.</p><p>Oswald A.E., Pye S.R., O'Neill T.W. et al. Prevalence and associated factors for falls in women with established inflammatory arthritis. J Rheumatol 2006; 33: 690-4.</p><p>Van Staa T.P., Geusens P., Bijlsma J.W.J. et al. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthr Rheum 2006; 54: 3104-12.</p><p>Gough A., Sambrook P., Devlin J. et al. Effect of vitamin D receptor gene alleles on bone loss in early rheumatoid arthritis. J Rheumatol 1998; 25: 864-8.</p><p>Rass P., Pakozdi A., Lakatos P. et al. Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatol Int 2006; 26: 964-71.</p><p>Oelzner P., Miller A., Deschner F. et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 1998; 62: 193-8.</p><p>Haugeberg G., Orstavik R.E., Uhlig T. et al. Bone loss in patients with rheumatoid arthritis: results from a population based cohort of 366 patients followed up for two years. Arthr Rheum 2002; 46: 1720-8.</p><p>Dawson-Hughes В., Heaney R.P., Holick M.F. et al. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713-6.</p><p>Trang H., Cole D.E., Rubin L.A. et al. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998; 68: 854-8.</p><p>Armas L.A.G., Hollis B.W., Heaney R.P. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004; 89: 5387-91.</p><p>Romagnoli E., Mascia M.L., Cipriani C. et al. Short and long term variation in serum calciotrophic hormones after a single very large dose of erogcalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrin Metab 2008; 93: 3015-20.</p><p>Vieth R., Kimball S., Hu A., Walfish P.G. Randomized comparison of the effect of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical response and the well-being of patients. Nutr J 2004; 3: 8-18.</p><p>Heaney R.P., Davies K.M., Chen T.C. et al. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003; 77: 204-10.</p><p>Andjelkovic Z., Vojinovic J., Pejnovic N. et al. Disease modifying and immunomodulatory effects of high dose 1alpha(OH)D3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999; 17: 453-6.</p><p>Гукасян Д.А. Остеопороз у больных ревматоидным артритом, его коррекция альфакальцидолом: Дис. ... канд. мед. наук. М., 2000.</p></div><br />